These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7846116)

  • 1. Calcium antagonists and vasodilatation.
    Godfraind T
    Pharmacol Ther; 1994 Oct; 64(1):37-75. PubMed ID: 7846116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioselectivity of calcium antagonists.
    Godfraind T
    Cardiovasc Drugs Ther; 1994 May; 8 Suppl 2():353-64. PubMed ID: 7947378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+ channel activation and membrane depolarization mediated by Cl- channels in response to noradrenaline in vascular myocytes.
    Pacaud P; Loirand G; Baron A; Mironneau C; Mironneau J
    Br J Pharmacol; 1991 Dec; 104(4):1000-6. PubMed ID: 1667281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
    Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
    J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do calcium antagonists differ in clinical practice?
    Ferrari R; Cucchini F; Bolognesi R; Bachetti T; Boraso A; Bernocchi P; Gaia G; Visioli O
    Cardiovasc Drugs Ther; 1994 Aug; 8 Suppl 3():565-75. PubMed ID: 7841090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-channel modulators for cardiovascular disease.
    Godfraind T
    Expert Opin Emerg Drugs; 2006 Mar; 11(1):49-73. PubMed ID: 16503826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the action of calcium antagonists in arteries.
    Godfraind T; Morel N; Wibo M
    Blood Vessels; 1990; 27(2-5):184-96. PubMed ID: 2173640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological dissection of Ca2+ channels in the rat aorta by Ca2+ entry modulators.
    Rico I; Alonso MJ; Salaices M; Marín J
    Pharmacology; 1990; 40(6):330-42. PubMed ID: 1700444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental pharmacology of calcium antagonists].
    Godfraind T
    Therapie; 1993; 48 Spec No():637-49. PubMed ID: 8091349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists. Great tissue selectivity is the basis of their therapeutic use].
    Högestätt ED; Andersson KE
    Lakartidningen; 1997 Sep; 94(36):3024-6, 3029-31. PubMed ID: 9312623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification and tissue selectivity of calcium antagonists.
    Nayler WG
    Z Kardiol; 1990; 79 Suppl 3():107-11. PubMed ID: 1965934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orai1 forms a signal complex with SK3 channel in gallbladder smooth muscle.
    Song K; Zhong XG; Xia XM; Huang JH; Fan YF; Yuan RX; Xue NR; Du J; Han WX; Xu AM; Shen B
    Biochem Biophys Res Commun; 2015 Oct; 466(3):456-62. PubMed ID: 26367175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L, P-/Q- and T-type Ca2+ channels in smooth muscle cells from human umbilical artery.
    Salemme S; Rebolledo A; Speroni F; Petruccelli S; Milesi V
    Cell Physiol Biochem; 2007; 20(1-4):55-64. PubMed ID: 17595515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Voltage-dependent L-type calcium channels--inhibition, function and modulation].
    Schleifer KJ
    Pharm Unserer Zeit; 1997 Jul; 26(4):179-86. PubMed ID: 9411449
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcium antagonists: concepts and recent progresses in research on the mechanism of action].
    Yoshida Y; Imai S
    Nihon Rinsho; 1989 Aug; 47(8):1714-8. PubMed ID: 2555587
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium entry blockade and excitation contraction coupling in the cardiovascular system (with an attempt of pharmacological classification).
    Godfraind T
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():5-30. PubMed ID: 2424268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of L-type calcium channels in hypoxic relaxation of vascular smooth muscle.
    Herrera GM; Walker BR
    J Vasc Res; 1998; 35(4):265-73. PubMed ID: 9701711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of voltage-gated L-type calcium channels by labedipinedilol-A involves protein kinase C in rat cerebrovascular smooth muscle cells.
    Wu BN; Chen ML; Dai ZK; Lin YL; Yeh JL; Wu JR; Chen IJ
    Vascul Pharmacol; 2009; 51(2-3):65-71. PubMed ID: 19298869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.